Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
It is very uncertain whether topical NSAID (ketoprofen chewing gum) changes pain intensity (VAS 0-100 mm) compared with local anaesthetic (benzocaine chewing gum) (very low certainty).
1 finding from 1 review
Intervention not reported
Development of portal hypertension · adults and children with cystic fibrosis‐related liver disease
1 finding from 1 review
Intervention not reported
Social support vs less intensive interventions 9 · Pregnant women who smoke
The intervention showed no clear difference in social support vs less intensive interventions 9 (high certainty).
1 finding from 1 review
Admission to neonatal intensive care unit · women in the second stage of labour without epidural anaesthesia
Any upright showed no clear difference in admission to neonatal intensive care unit compared with supine position (low certainty).
1 finding from 1 review
Hypertension · Neonates with developing BPD
Inhaled steroids may leads to lower hypertension compared with systemic steroids (low certainty).
1 finding from 1 review
Back pain · Subacute low back pain
1 finding from 1 review
Pain at the long term Higher scores indicated more intense pain · Subacute low back pain
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · people with cancer pain
Methadone may leads to higher participant‐reported pain intensity compared with morphine (low certainty).
1 finding from 1 review
Hypotension · prevention of necrotising enterocolitis in preterm infants
Arginine showed no clear difference in side effects ‐ hypotension compared with placebo (moderate certainty).
1 finding from 1 review
Admission to neonatal intensive care unit · preterm prelabour rupture of membranes (PPROM)
Planned early birth probably leads to higher admission to neonatal intensive care compared with expectant management (moderate certainty).
1 finding from 1 review
Major adverse event: hypotension · patients with supraventricular tachycardia
1 finding from 1 review
no estimate extracted
306 participants
Low
Serious maternal morbidity or death · women with prelabour rupture of membranes at term (37 weeks' gestation or later)
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · adults and paediatric patients with dermal laceration
5 findings from 1 review
no estimate extracted
6 studies · 1006 participants
Low
no estimate extracted
4 studies · 530 participants
Low
no estimate extracted
6 studies · 543 participants
Low
Show 2 more findings
Hypertensive disorders of pregnancy · pregnant women
1 finding from 1 review
Hypertensive disorders of pregnancy (pregnancy‐induced hypertension) · pregnant women
Dietary advice interventions may leads to lower hypertensive disorders of pregnancy (pregnancy‐induced hypertension) compared with standard care (maternal outcomes) (low certainty).
1 finding from 1 review
Hypertensive disorders of pregnancy: pre‐eclampsia · pregnant women
Dietary advice interventions showed no clear difference in hypertensive disorders of pregnancy (pre‐eclampsia) compared with standard care (maternal outcomes) (low certainty).
1 finding from 1 review
Adverse events: hypertension · kidney transplant recipients
Low dose calcineurin inhibitors (CNI) showed no clear difference in adverse events: hypertension compared with to standard dose CNI (low certainty).
1 finding from 1 review
Adverse events: hypertension · kidney transplant recipients
Calcineurin inhibitor (CNI) withdrawal + mammalian target of… showed no clear difference in adverse events: hypertension compared with standard dose CNI (low certainty).
1 finding from 1 review
Adverse events: hypertension · kidney transplant recipients
Low dose CNI calcineurin inhibitor (CNI) + mammalian target of… showed no clear difference in adverse events: hypertension compared with standard dose CNI (low certainty).
1 finding from 1 review